美單日新增12.21萬宗新冠確診 佛州州長入稟挑戰強制接種疫苗規定
美國新冠疫情持續。據美國約翰霍普金斯大學統計,美國截至西岸時間午夜(本港時間下午3時),累計新冠確診45,826,141宗,單日新增122,127宗。累計死亡個案743,359宗,單日新增2,127宗。
花旗集團(C.US)引用美國總統拜登有關聯邦外判商的疫苗接種規定,向美國員工表明完成接種疫苗將成爲聘用條件。另一方面,一直反對強制防疫措施的共和黨籍佛羅裏達州州長Ron DeSantis入稟法院,挑戰拜登對聯邦政府外判商的強制疫苗接種規定,指違反採購法例。他亦因不滿當地有學校堅持口罩令及疫苗規定,扣起對兩個校區撥款。美國教育部早前已向法院要求禁制州政府扣起聯邦政府給予校區的款項。
美國過去八日每日新冠疫情統計:
日期│累計確診│單日新增確診│累計死亡│單日新增死亡
10月28日(四)│45,826,141宗│+122,127宗│743,359宗│+2,127宗
10月27日(三)│45,704,014宗│+ 94,961宗│741,232宗│+2,351宗
10月26日(二)│45,609,053宗│+ 63,460宗│738,881宗│+1,563宗
10月25日(一)│45,545,593宗│+101,309宗│737,318宗│+1,377宗
10月24日(日)│45,444,284宗│+ 16,780宗│735,941宗│+ 140宗
10月23日(六)│45,427,504宗│+ 26,998宗│735,801宗│+ 427宗
10月22日(五)│45,400,506宗│+ 99,507宗│735,374宗│+2,157宗
10月21日(四)│45,300,999宗│+ 82,035宗│733,217宗│+1,952宗
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.